SynthesisTransboundary and emerging diseases2026
Brucellosis in Southeast Asia: A Systematic Review of Epidemiological Evidence, Surveillance Gaps, and cgMLST-Based Insights Into Genetic Relatedness.
Synthesis in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Brucellosis in Southeast Asia: A Systematic Review of Epidemiological Evidence, Surveillance Gaps, and cgMLST-Based Insights Into Genetic Relatedness.Transboundary and emerging diseases · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Brucellosis is an important zoonosis affecting public health and livestock production in Southeast Asia, but its regional epidemiology remains incompletely characterized. In this study, PubMed, Embase, Web of Science, and Scopus were searched for primary studies from the 11 Southeast Asian countries that reported serological findings, molecular detection, bacterial isolation, or Brucella species identification in human or animal populations. Publicly available PubMLST records were also analyzed using the 1764-locus Brucella core-genome multilocus sequence typing scheme. Across the eligible studies, reported crude seropositivity proportions ranged from 0.72% to 5.40% in humans and from 0.24% to 8.83% in animals. Molecular evidence included PCR positivity rates of 3.36% in goat vaginal swabs from Thailand and 39.2% in a selected mixed-livestock population from Indonesia, together with the identification of Brucella melitensis, B. abortus, and B. suis in several Southeast Asian countries. These findings provide epidemiological evidence of brucellosis in several countries. cgMLST analysis of the 24 available profiles from Malaysia and Thailand revealed close genetic relatedness among several isolates. Malaysian and Thai B. melitensis isolates differed by fewer than 11 alleles within the main cluster and by 41-81 alleles relative to isolates from India and the United Kingdom. Two Thai B. abortus isolates differed at only one locus and by 68-150 alleles from isolates from Bangladesh, India, and Bolivia, whereas five Malaysian B. suis isolates differed by 7-78 alleles, indicating limited genetic diversity within the Malaysian cluster. Additional genomic and epidemiological data are needed to determine whether genetically similar isolates are epidemiologically linked. Brucellosis appears endemic in parts of Southeast Asia, but important gaps in published data remain. Integrated One Health surveillance is needed to improve regional risk assessment and control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.